ReP USP - Resultado da busca

Artigo de periodico
Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats (2024)
Souza, Aline de ; Scarim, Cauê Benito ; Cotrim, Paulo César ; Barbosa Junior, Fernando ; Rocha, Bruno Alves ; Calixto, Leandro Augusto ; Correia, Cristiano de Jesus; Araujo, Gabriel Lima Barros de ; Löbenberg, Raimar ; Bou-Chacra, Nadia Araci ; Faloppa, Ana Cristina Breithaupt
Source: Nanomedicine. Unidades: FM, FCFRP, FCF
Subjects: LEISHMANIA, SISTEMA LINFÁTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Aline de et al. Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats. Nanomedicine, v. 19, n. 4, p. 293-301, 2024Tradução . . Disponível em: https://dx.doi.org/10.2217/nnm-2023-0263. Acesso em: 14 nov. 2024.
APA
Souza, A. de, Scarim, C. B., Cotrim, P. C., Barbosa Junior, F., Rocha, B. A., Calixto, L. A., et al. (2024). Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats. Nanomedicine, 19( 4), 293-301. doi:10.2217/nnm-2023-0263
NLM
Souza A de, Scarim CB, Cotrim PC, Barbosa Junior F, Rocha BA, Calixto LA, Correia C de J, Araujo GLB de, Löbenberg R, Bou-Chacra NA, Faloppa ACB. Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats [Internet]. Nanomedicine. 2024 ; 19( 4): 293-301.[citado 2024 nov. 14 ] Available from: https://dx.doi.org/10.2217/nnm-2023-0263
Vancouver
Souza A de, Scarim CB, Cotrim PC, Barbosa Junior F, Rocha BA, Calixto LA, Correia C de J, Araujo GLB de, Löbenberg R, Bou-Chacra NA, Faloppa ACB. Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats [Internet]. Nanomedicine. 2024 ; 19( 4): 293-301.[citado 2024 nov. 14 ] Available from: https://dx.doi.org/10.2217/nnm-2023-0263
Artigo de periodico
Advanced drug-delivery approaches in managing P53-mediated lung diseases remodeling (2023)
Bhat, Asif Ahmad ; Gilhotra, Ritu; Singh, Yogendra; Sharma, Sanjay; Pinto, Terezinha de Jesus Andreoli ; Ferraz, Humberto Gomes ; Singh, Sachin Kumar ; Dua, Kamal ; Gupta, Gaurav
Source: Nanomedicine. Unidade: FCF
Subjects: DOENÇA PULMONAR OBSTRUTIVA CRÔNICA, NANOPARTÍCULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BHAT, Asif Ahmad et al. Advanced drug-delivery approaches in managing P53-mediated lung diseases remodeling. Nanomedicine, v. 18, n. 7, p. 583-587, 2023Tradução . . Disponível em: https://doi.org/10.2217/nnm-2023-0032. Acesso em: 14 nov. 2024.
APA
Bhat, A. A., Gilhotra, R., Singh, Y., Sharma, S., Pinto, T. de J. A., Ferraz, H. G., et al. (2023). Advanced drug-delivery approaches in managing P53-mediated lung diseases remodeling. Nanomedicine, 18( 7), 583-587. doi:10.2217/nnm-2023-0032
NLM
Bhat AA, Gilhotra R, Singh Y, Sharma S, Pinto T de JA, Ferraz HG, Singh SK, Dua K, Gupta G. Advanced drug-delivery approaches in managing P53-mediated lung diseases remodeling [Internet]. Nanomedicine. 2023 ; 18( 7): 583-587.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2217/nnm-2023-0032
Vancouver
Bhat AA, Gilhotra R, Singh Y, Sharma S, Pinto T de JA, Ferraz HG, Singh SK, Dua K, Gupta G. Advanced drug-delivery approaches in managing P53-mediated lung diseases remodeling [Internet]. Nanomedicine. 2023 ; 18( 7): 583-587.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2217/nnm-2023-0032
Artigo de periodico
Topical transdermal chemoprevention of breast cancer: where will nanomedical approaches deliver us? (2021)
Mojeiko, Gabriela; Passos, Julia Sapienza ; Apolinário, Alexsandra Conceição ; Lopes, Luciana Biagini
Source: Nanomedicine. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOJEIKO, Gabriela et al. Topical transdermal chemoprevention of breast cancer: where will nanomedical approaches deliver us?. Nanomedicine, v. 16, n. 19, p. 1713–1731, 2021Tradução . . Disponível em: https://doi.org/10.2217/nnm-2021-0130. Acesso em: 14 nov. 2024.
APA
Mojeiko, G., Passos, J. S., Apolinário, A. C., & Lopes, L. B. (2021). Topical transdermal chemoprevention of breast cancer: where will nanomedical approaches deliver us? Nanomedicine, 16( 19), 1713–1731. doi:10.2217/nnm-2021-0130
NLM
Mojeiko G, Passos JS, Apolinário AC, Lopes LB. Topical transdermal chemoprevention of breast cancer: where will nanomedical approaches deliver us? [Internet]. Nanomedicine. 2021 ; 16( 19): 1713–1731.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2217/nnm-2021-0130
Vancouver
Mojeiko G, Passos JS, Apolinário AC, Lopes LB. Topical transdermal chemoprevention of breast cancer: where will nanomedical approaches deliver us? [Internet]. Nanomedicine. 2021 ; 16( 19): 1713–1731.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2217/nnm-2021-0130
Artigo de periodico
Licochalcone A-loaded solid lipid nanoparticles improve antischistosomal activity in vitro and in vivo (2021)
Silva, Lívia Mara; Marconato, Danielle Gomes; Silva, Marcos Paulo Nascimento da; Raposo, Nádia Rezende Barbosa; Facchini, Gabriela de Faria Silva; Macedo, Gilson Costa; Teixeira, Fernanda de Sá; Salvadori, M. C. ; Pinto, Priscila de Faria; Moraes, Josué de; Pittella, Frederico; Da Silva Filho, A. A.
Source: Nanomedicine. Unidade: IF
Subjects: NANOTECNOLOGIA, FENÓIS, PRODUTOS NATURAIS, ESQUISTOSSOMOSE MANSONI, MICROSCOPIA ELETRÔNICA, ANTI-HELMÍNTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Lívia Mara et al. Licochalcone A-loaded solid lipid nanoparticles improve antischistosomal activity in vitro and in vivo. Nanomedicine, p. 15 , 2021Tradução . . Disponível em: https://doi.org/10.2217/nnm-2021-0146. Acesso em: 14 nov. 2024.
APA
Silva, L. M., Marconato, D. G., Silva, M. P. N. da, Raposo, N. R. B., Facchini, G. de F. S., Macedo, G. C., et al. (2021). Licochalcone A-loaded solid lipid nanoparticles improve antischistosomal activity in vitro and in vivo. Nanomedicine, 15 . doi:10.2217/nnm-2021-0146
NLM
Silva LM, Marconato DG, Silva MPN da, Raposo NRB, Facchini G de FS, Macedo GC, Teixeira F de S, Salvadori MC, Pinto P de F, Moraes J de, Pittella F, Da Silva Filho AA. Licochalcone A-loaded solid lipid nanoparticles improve antischistosomal activity in vitro and in vivo [Internet]. Nanomedicine. 2021 ;15 .[citado 2024 nov. 14 ] Available from: https://doi.org/10.2217/nnm-2021-0146
Vancouver
Silva LM, Marconato DG, Silva MPN da, Raposo NRB, Facchini G de FS, Macedo GC, Teixeira F de S, Salvadori MC, Pinto P de F, Moraes J de, Pittella F, Da Silva Filho AA. Licochalcone A-loaded solid lipid nanoparticles improve antischistosomal activity in vitro and in vivo [Internet]. Nanomedicine. 2021 ;15 .[citado 2024 nov. 14 ] Available from: https://doi.org/10.2217/nnm-2021-0146
Artigo de periodico
Nanostructured lipid carriers enhances the safety profile of tretinoin: in vitro and healthy human volunteers’ studies (2021)
Lima, Flávia Afonso ; Vilela, Raquel V. R ; Orefice, Rodrigo L ; Silva, Izabela R ; Reis, Eduardo C. O ; Carvalho, Larissa Anastácio da Costa ; Maria-Engler, Silvya Stuchi ; Ferreira, Lucas A. M ; Goulart, Gisele A. C
Source: Nanomedicine. Unidade: FCF
Subjects: LIPÍDEOS, EXPRESSÃO GÊNICA, NANOPARTÍCULAS, PELE ARTIFICIAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Flávia Afonso et al. Nanostructured lipid carriers enhances the safety profile of tretinoin: in vitro and healthy human volunteers’ studies. Nanomedicine, v. 16, n. 16, p. 1391–1409, 2021Tradução . . Disponível em: https://doi.org/10.2217/nnm-2021-0031. Acesso em: 14 nov. 2024.
APA
Lima, F. A., Vilela, R. V. R., Orefice, R. L., Silva, I. R., Reis, E. C. O., Carvalho, L. A. da C., et al. (2021). Nanostructured lipid carriers enhances the safety profile of tretinoin: in vitro and healthy human volunteers’ studies. Nanomedicine, 16( 16), 1391–1409. doi:10.2217/nnm-2021-0031
NLM
Lima FA, Vilela RVR, Orefice RL, Silva IR, Reis ECO, Carvalho LA da C, Maria-Engler SS, Ferreira LAM, Goulart GAC. Nanostructured lipid carriers enhances the safety profile of tretinoin: in vitro and healthy human volunteers’ studies [Internet]. Nanomedicine. 2021 ; 16( 16): 1391–1409.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2217/nnm-2021-0031
Vancouver
Lima FA, Vilela RVR, Orefice RL, Silva IR, Reis ECO, Carvalho LA da C, Maria-Engler SS, Ferreira LAM, Goulart GAC. Nanostructured lipid carriers enhances the safety profile of tretinoin: in vitro and healthy human volunteers’ studies [Internet]. Nanomedicine. 2021 ; 16( 16): 1391–1409.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2217/nnm-2021-0031
Artigo de periodico
In vivo evaluation of toxicity and anti-inflammatory activity of iron oxide nanoparticles conjugated with ibuprofen (2021)
Uchiyama, Mayara Klimuk ; Hebeda, Cristina Bichels ; Sandri, Silvana ; Silva, Marina de Paula ; Romano, Mariana ; Cardoso, Roberta Mansini ; Toma, Sérgio Hiroshi ; Araki, Koiti ; Farsky, Sandra Helena Poliselli
Source: Nanomedicine. Unidades: FO, IQ, FCF
Subjects: NANOPARTÍCULAS, FERRO, ANTI-INFLAMATÓRIOS, IMUNIDADE, PERITONITE, LIPOPOLISSACARÍDEOS, NEUTRÓFILOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
UCHIYAMA, Mayara Klimuk et al. In vivo evaluation of toxicity and anti-inflammatory activity of iron oxide nanoparticles conjugated with ibuprofen. Nanomedicine, v. 16, n. 9, p. 741–758, 2021Tradução . . Disponível em: https://doi.org/10.2217/nnm-2020-0459. Acesso em: 14 nov. 2024.
APA
Uchiyama, M. K., Hebeda, C. B., Sandri, S., Silva, M. de P., Romano, M., Cardoso, R. M., et al. (2021). In vivo evaluation of toxicity and anti-inflammatory activity of iron oxide nanoparticles conjugated with ibuprofen. Nanomedicine, 16( 9), 741–758. doi:10.2217/nnm-2020-0459
NLM
Uchiyama MK, Hebeda CB, Sandri S, Silva M de P, Romano M, Cardoso RM, Toma SH, Araki K, Farsky SHP. In vivo evaluation of toxicity and anti-inflammatory activity of iron oxide nanoparticles conjugated with ibuprofen [Internet]. Nanomedicine. 2021 ; 16( 9): 741–758.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2217/nnm-2020-0459
Vancouver
Uchiyama MK, Hebeda CB, Sandri S, Silva M de P, Romano M, Cardoso RM, Toma SH, Araki K, Farsky SHP. In vivo evaluation of toxicity and anti-inflammatory activity of iron oxide nanoparticles conjugated with ibuprofen [Internet]. Nanomedicine. 2021 ; 16( 9): 741–758.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2217/nnm-2020-0459
Artigo de periodico
Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases (2021)
Chan, Yinghan ; MacLoughlin, Ronan ; Tambuwala, Murtaza M ; Pabari, Ritesh M ; Singh, Sachin Kumar ; Pinto, Terezinha de Jesus Andreoli ; Gupta, Gaurav ; Chellappan, Dinesh Kumar ; Dua, Kamal
Source: Nanomedicine. Unidade: FCF
Subjects: DOENÇAS RESPIRATÓRIAS, NANOTECNOLOGIA, INFLAMAÇÃO, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAN, Yinghan et al. Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases. Nanomedicine, v. 16, n. 16, p. 1351–1355, 2021Tradução . . Disponível em: https://doi.org/10.2217/nnm-2021-0087. Acesso em: 14 nov. 2024.
APA
Chan, Y., MacLoughlin, R., Tambuwala, M. M., Pabari, R. M., Singh, S. K., Pinto, T. de J. A., et al. (2021). Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases. Nanomedicine, 16( 16), 1351–1355. doi:10.2217/nnm-2021-0087
NLM
Chan Y, MacLoughlin R, Tambuwala MM, Pabari RM, Singh SK, Pinto T de JA, Gupta G, Chellappan DK, Dua K. Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases [Internet]. Nanomedicine. 2021 ; 16( 16): 1351–1355.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2217/nnm-2021-0087
Vancouver
Chan Y, MacLoughlin R, Tambuwala MM, Pabari RM, Singh SK, Pinto T de JA, Gupta G, Chellappan DK, Dua K. Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases [Internet]. Nanomedicine. 2021 ; 16( 16): 1351–1355.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2217/nnm-2021-0087
Artigo de periodico
Nitric oxide inhibition of lipopolysaccharide-stimulated RAW 247.6 cells by ibuprofen-conjugated iron oxide nanoparticles (2020)
Romano, Mariana ; Uchiyama, Mayara Klimuk ; Cardoso, Roberta Mansini ; Toma, Sérgio Hiroshi ; Baptista, Maurício da Silva ; Araki, Koiti
Source: Nanomedicine. Unidades: IQ, FO
Subjects: NANOPARTÍCULAS, MACRÓFAGOS, ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROMANO, Mariana et al. Nitric oxide inhibition of lipopolysaccharide-stimulated RAW 247.6 cells by ibuprofen-conjugated iron oxide nanoparticles. Nanomedicine, v. 15, n. 25, p. 2475–2492, 2020Tradução . . Disponível em: https://doi.org/10.2217/nnm-2020-0214. Acesso em: 14 nov. 2024.
APA
Romano, M., Uchiyama, M. K., Cardoso, R. M., Toma, S. H., Baptista, M. da S., & Araki, K. (2020). Nitric oxide inhibition of lipopolysaccharide-stimulated RAW 247.6 cells by ibuprofen-conjugated iron oxide nanoparticles. Nanomedicine, 15( 25), 2475–2492. doi:10.2217/nnm-2020-0214
NLM
Romano M, Uchiyama MK, Cardoso RM, Toma SH, Baptista M da S, Araki K. Nitric oxide inhibition of lipopolysaccharide-stimulated RAW 247.6 cells by ibuprofen-conjugated iron oxide nanoparticles [Internet]. Nanomedicine. 2020 ; 15( 25): 2475–2492.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2217/nnm-2020-0214
Vancouver
Romano M, Uchiyama MK, Cardoso RM, Toma SH, Baptista M da S, Araki K. Nitric oxide inhibition of lipopolysaccharide-stimulated RAW 247.6 cells by ibuprofen-conjugated iron oxide nanoparticles [Internet]. Nanomedicine. 2020 ; 15( 25): 2475–2492.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2217/nnm-2020-0214
Artigo de periodico
Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline (2020)
Apolinário, Alexsandra Conceição ; Hirata, Amanda Soares ; Miguel, Rodrigo dos Anjos ; Costa-Lotufo, Letícia Veras ; Pessoa Junior, Adalberto ; Clair, James J. La ; Fenical, William ; Lopes, Luciana Biagini
Source: Nanomedicine. Unidades: ICB, FCF
Subjects: FARMACOLOGIA, NEOPLASIAS MAMÁRIAS, NANOTECNOLOGIA, ANTINEOPLÁSICOS, QUIMIOTERÁPICOS, MELANOMA, FARMACOS, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
APOLINÁRIO, Alexsandra Conceição et al. Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline. Nanomedicine, v. 15, n. 26, p. 2539–2542, 2020Tradução . . Disponível em: https://doi.org/10.2217/nnm-2020-0290. Acesso em: 14 nov. 2024.
APA
Apolinário, A. C., Hirata, A. S., Miguel, R. dos A., Costa-Lotufo, L. V., Pessoa Junior, A., Clair, J. J. L., et al. (2020). Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline. Nanomedicine, 15( 26), 2539–2542. doi:10.2217/nnm-2020-0290
NLM
Apolinário AC, Hirata AS, Miguel R dos A, Costa-Lotufo LV, Pessoa Junior A, Clair JJL, Fenical W, Lopes LB. Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline [Internet]. Nanomedicine. 2020 ; 15( 26): 2539–2542.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2217/nnm-2020-0290
Vancouver
Apolinário AC, Hirata AS, Miguel R dos A, Costa-Lotufo LV, Pessoa Junior A, Clair JJL, Fenical W, Lopes LB. Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline [Internet]. Nanomedicine. 2020 ; 15( 26): 2539–2542.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2217/nnm-2020-0290
Artigo de periodico
Direct effects of poly(ε-caprolactone) lipid-core nanocapsules on human immune cells (2019)
Sandri, Silvana; Hebeda, Cristina Bichels ; Loiola, Rodrigo Azevedo; Calgaroto, Selma ; Uchiyama, Mayara Klimuk ; Araki, Koiti ; Frank, Luiza Abrahao ; Paese, Karina; Guterres, Sílvia Stanisçuaski ; Pohlmann, Adriana Raffin ; Farsky, Sandra Helena Poliselli
Source: Nanomedicine. Unidades: IQ, FCF
Subjects: IMUNOSSUPRESSÃO, CITOCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANDRI, Silvana et al. Direct effects of poly(ε-caprolactone) lipid-core nanocapsules on human immune cells. Nanomedicine, v. 14, n. 11, p. 1429-1442, 2019Tradução . . Disponível em: https://doi.org/10.2217/nnm-2018-0484. Acesso em: 14 nov. 2024.
APA
Sandri, S., Hebeda, C. B., Loiola, R. A., Calgaroto, S., Uchiyama, M. K., Araki, K., et al. (2019). Direct effects of poly(ε-caprolactone) lipid-core nanocapsules on human immune cells. Nanomedicine, 14( 11), 1429-1442. doi:10.2217/nnm-2018-0484
NLM
Sandri S, Hebeda CB, Loiola RA, Calgaroto S, Uchiyama MK, Araki K, Frank LA, Paese K, Guterres SS, Pohlmann AR, Farsky SHP. Direct effects of poly(ε-caprolactone) lipid-core nanocapsules on human immune cells [Internet]. Nanomedicine. 2019 ; 14( 11): 1429-1442.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2217/nnm-2018-0484
Vancouver
Sandri S, Hebeda CB, Loiola RA, Calgaroto S, Uchiyama MK, Araki K, Frank LA, Paese K, Guterres SS, Pohlmann AR, Farsky SHP. Direct effects of poly(ε-caprolactone) lipid-core nanocapsules on human immune cells [Internet]. Nanomedicine. 2019 ; 14( 11): 1429-1442.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2217/nnm-2018-0484
Artigo de periodico
A multilamellar nanoliposome stabilized by interlayer hydrogen bonds increases antimalarial drug efficacy (2019)
Fotoran, Wesley Luzetti; Müntefering, Thomas; Kleiber, Nicole; Miranda, Beatriz N.M.; Liebau, Eva; Irvine, Darrell J.; Wunderlich, Gerhard
Source: Nanomedicine. Unidade: ICB
Subjects: PARASITOLOGIA, ANTIMALÁRICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FOTORAN, Wesley Luzetti et al. A multilamellar nanoliposome stabilized by interlayer hydrogen bonds increases antimalarial drug efficacy. Nanomedicine, v. 22, p. 1-11, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.nano.2019.102099. Acesso em: 14 nov. 2024.
APA
Fotoran, W. L., Müntefering, T., Kleiber, N., Miranda, B. N. M., Liebau, E., Irvine, D. J., & Wunderlich, G. (2019). A multilamellar nanoliposome stabilized by interlayer hydrogen bonds increases antimalarial drug efficacy. Nanomedicine, 22, 1-11. doi:10.1016/j.nano.2019.102099
NLM
Fotoran WL, Müntefering T, Kleiber N, Miranda BNM, Liebau E, Irvine DJ, Wunderlich G. A multilamellar nanoliposome stabilized by interlayer hydrogen bonds increases antimalarial drug efficacy [Internet]. Nanomedicine. 2019 ;22 1-11.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.nano.2019.102099
Vancouver
Fotoran WL, Müntefering T, Kleiber N, Miranda BNM, Liebau E, Irvine DJ, Wunderlich G. A multilamellar nanoliposome stabilized by interlayer hydrogen bonds increases antimalarial drug efficacy [Internet]. Nanomedicine. 2019 ;22 1-11.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.nano.2019.102099
Artigo de periodico
Protein nanoparticles are nontoxic, tuneable cell stressors (2018)
Favaro, Marianna Teixeira de Pinho ; Sánchez-García, Laura ; Sanchez-Chardi, Alejandro ; Roldán, Mónica; Unzueta, Ugutz ; Serna, Naroa; Cano-Garrido, Olivia ; Azzoni, Adriano Rodrigues ; Ferrer-Miralles, Neus ; Villaverde, Antonio ; Vázquez, Esther
Source: Nanomedicine. Unidade: EP
Subjects: PROTEÍNAS, NANOPARTÍCULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAVARO, Marianna Teixeira de Pinho et al. Protein nanoparticles are nontoxic, tuneable cell stressors. Nanomedicine, v. 13, n. 3, p. 255-268, 2018Tradução . . Disponível em: https://doi.org/10.2217/nnm-2017-0294. Acesso em: 14 nov. 2024.
APA
Favaro, M. T. de P., Sánchez-García, L., Sanchez-Chardi, A., Roldán, M., Unzueta, U., Serna, N., et al. (2018). Protein nanoparticles are nontoxic, tuneable cell stressors. Nanomedicine, 13( 3), 255-268. doi:10.2217/nnm-2017-0294
NLM
Favaro MT de P, Sánchez-García L, Sanchez-Chardi A, Roldán M, Unzueta U, Serna N, Cano-Garrido O, Azzoni AR, Ferrer-Miralles N, Villaverde A, Vázquez E. Protein nanoparticles are nontoxic, tuneable cell stressors [Internet]. Nanomedicine. 2018 ; 13( 3): 255-268.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2217/nnm-2017-0294
Vancouver
Favaro MT de P, Sánchez-García L, Sanchez-Chardi A, Roldán M, Unzueta U, Serna N, Cano-Garrido O, Azzoni AR, Ferrer-Miralles N, Villaverde A, Vázquez E. Protein nanoparticles are nontoxic, tuneable cell stressors [Internet]. Nanomedicine. 2018 ; 13( 3): 255-268.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2217/nnm-2017-0294
Artigo de periodico
Self-nanoemulsifying drug-delivery systems improve oral absorption and antischistosomal activity of epiisopiloturine (2018)
Lima, Luiza Ianny de; Py-Daniel, Karen Rapp; Guimarães, Maria Adelaide; Muehlmann, Luís Alexandre; Mafud, Ana Carolina; Mascarenhas, Yvonne Primerano ; Moraes, Josué de; Leite, José Roberto de Souza de Almeida; Jiang, Cheng-Shi; Azevedo, Ricardo Bentes; Longo, João Paulo Figueiró
Source: Nanomedicine. Unidade: IFSC
Subjects: ESQUISTOSSOMOSE, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Luiza Ianny de et al. Self-nanoemulsifying drug-delivery systems improve oral absorption and antischistosomal activity of epiisopiloturine. Nanomedicine, v. 13, n. 7, p. 689-702, 2018Tradução . . Disponível em: https://doi.org/10.2217/nnm-2017-0308. Acesso em: 14 nov. 2024.
APA
Lima, L. I. de, Py-Daniel, K. R., Guimarães, M. A., Muehlmann, L. A., Mafud, A. C., Mascarenhas, Y. P., et al. (2018). Self-nanoemulsifying drug-delivery systems improve oral absorption and antischistosomal activity of epiisopiloturine. Nanomedicine, 13( 7), 689-702. doi:10.2217/nnm-2017-0308
NLM
Lima LI de, Py-Daniel KR, Guimarães MA, Muehlmann LA, Mafud AC, Mascarenhas YP, Moraes J de, Leite JR de S de A, Jiang C-S, Azevedo RB, Longo JPF. Self-nanoemulsifying drug-delivery systems improve oral absorption and antischistosomal activity of epiisopiloturine [Internet]. Nanomedicine. 2018 ; 13( 7): 689-702.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2217/nnm-2017-0308
Vancouver
Lima LI de, Py-Daniel KR, Guimarães MA, Muehlmann LA, Mafud AC, Mascarenhas YP, Moraes J de, Leite JR de S de A, Jiang C-S, Azevedo RB, Longo JPF. Self-nanoemulsifying drug-delivery systems improve oral absorption and antischistosomal activity of epiisopiloturine [Internet]. Nanomedicine. 2018 ; 13( 7): 689-702.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2217/nnm-2017-0308
Artigo de periodico
Effective transcutaneous immunization using a combination of iontophoresis and nanoparticles (2016)
Bernardi, Daniela S.; Bitencourt, Claudia; Silveira, Denise S. C.; Cruz, Estael L. C. M.; Silva, Marcelo de Assumpção Pereira da ; Faccioli, Lúcia Helena; Lopez, Renata F. V.
Source: Nanomedicine. Unidades: IFSC, FCFRP
Subjects: NANOPARTÍCULAS, PRATA, LIPOSSOMOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BERNARDI, Daniela S. et al. Effective transcutaneous immunization using a combination of iontophoresis and nanoparticles. Nanomedicine, v. No 2016, n. 08, p. 2439-2448, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.nano.2016.07.001. Acesso em: 14 nov. 2024.
APA
Bernardi, D. S., Bitencourt, C., Silveira, D. S. C., Cruz, E. L. C. M., Silva, M. de A. P. da, Faccioli, L. H., & Lopez, R. F. V. (2016). Effective transcutaneous immunization using a combination of iontophoresis and nanoparticles. Nanomedicine, No 2016( 08), 2439-2448. doi:10.1016/j.nano.2016.07.001
NLM
Bernardi DS, Bitencourt C, Silveira DSC, Cruz ELCM, Silva M de AP da, Faccioli LH, Lopez RFV. Effective transcutaneous immunization using a combination of iontophoresis and nanoparticles [Internet]. Nanomedicine. 2016 ; No 2016( 08): 2439-2448.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.nano.2016.07.001
Vancouver
Bernardi DS, Bitencourt C, Silveira DSC, Cruz ELCM, Silva M de AP da, Faccioli LH, Lopez RFV. Effective transcutaneous immunization using a combination of iontophoresis and nanoparticles [Internet]. Nanomedicine. 2016 ; No 2016( 08): 2439-2448.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.nano.2016.07.001
Artigo de periodico-carta/editorial
Nanoneurobiophysics: new challenges for diagnosis and therapy of neurologic disorders [Editorial] (2015)
Leite, Fabio L.; Hausen, Moema; Oliveira, Guedmiller S.; Brum, Doralina G.; Oliveira Junior, Osvaldo Novais de
Source: Nanomedicine. Unidade: IFSC
Subjects: DOENÇAS, DIAGNÓSTICO, MICROSCOPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEITE, Fabio L. et al. Nanoneurobiophysics: new challenges for diagnosis and therapy of neurologic disorders [Editorial]. Nanomedicine. London: Instituto de Física de São Carlos, Universidade de São Paulo. Disponível em: https://doi.org/10.2217/nnm.15.164. Acesso em: 14 nov. 2024. , 2015
APA
Leite, F. L., Hausen, M., Oliveira, G. S., Brum, D. G., & Oliveira Junior, O. N. de. (2015). Nanoneurobiophysics: new challenges for diagnosis and therapy of neurologic disorders [Editorial]. Nanomedicine. London: Instituto de Física de São Carlos, Universidade de São Paulo. doi:10.2217/nnm.15.164
NLM
Leite FL, Hausen M, Oliveira GS, Brum DG, Oliveira Junior ON de. Nanoneurobiophysics: new challenges for diagnosis and therapy of neurologic disorders [Editorial] [Internet]. Nanomedicine. 2015 ; 10( 23): 3417-3419.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2217/nnm.15.164
Vancouver
Leite FL, Hausen M, Oliveira GS, Brum DG, Oliveira Junior ON de. Nanoneurobiophysics: new challenges for diagnosis and therapy of neurologic disorders [Editorial] [Internet]. Nanomedicine. 2015 ; 10( 23): 3417-3419.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2217/nnm.15.164

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Grupo de pesquisa

Funding Agencies

Non normalized affiliation

Countries of institutions of collaboration